Roger Y. Tsang
Positions
Clinical Assistant Professor
Cumming School of Medicine, Department of Oncology
Medical Oncologist
Arthur J.E. Child Comprehensive Cancer Centre
Member
Arnie Charbonneau Cancer Institute
Contact information
Web presence
Phone number
Office: 587.231.6051
Background
Educational Background
Bachelor of Medical Science (BMSc) , University of Alberta, 2003
Doctor of Medicine (MD) with Special Training in Research , University of Alberta, 2004
Internal Medicine , Fellow of the Royal College of Physicians of Canada (FRCPC), 2008
Medical Oncology , Sub-Specialty Certification, Royal College of Physicians of Canada, 2009
Biography
Dr. Tsang is a staff medical oncologist at the Arthur J.E. Child Comprehensive Cancer Centre in Calgary. He obtained his MD with Special Training in Research at the University of Alberta, followed by Internal Medicine and Medical Oncology residency training in Edmonton. He completed a Translational Oncology research fellowship at UCLA in Los Angeles, California. In 2020, he received an Evidence-Based Medicine teaching award from the Medical Oncology residency training program. He is passionate about health informatics, and the intersection of information technology, data science, and clinical medicine to enhance patient care and improve outcomes. Since 2018, he has served as a Medical Informatics Lead in Medical Oncology, Calgary Zone, with AHS Connect Care.
Research
Areas of Research
- Breast Cancer
- Neuro-Oncology (CNS Cancers)
Dr. Tsang is an active participant in local, cooperative group, and industry-sponsored research studies in breast and central nervous system (CNS) cancers. He is the site PI for Canadian Cancer Trials Group (CCTG) CEC.6 [ALLIANCE N0577], a phase III clinical trial evaluating temozolomide versus PCV chemotherapy in patients with 1p/19q co-deleted gliomas. He is a co-investigator in a phase I/II study evaluating niacin in patients with newly diagnosed glioblastoma. He is the Qualified Investigator (QI) for a study evaluating a novel breast imaging technique using a transmission-based microwave imaging system (PI: Fear), and a co-investigator in a related study evaluating its use in patients receiving neoadjuvant systemic therapy. He enjoys conducting multi-disciplinary translational cancer research in collaboration with other investigators. He also serves as a physician member on the CCTG Audit and Monitoring Committee.
Are you the profile owner?
Login to edit.